ISOFOL MEDICAL AB

Share · SE0009581051 · A2DPV6 (XSTO)

Overview

No Price

Closing Price XSTO 31.10.2025: 0,69 SEK

31.10.2025 11:54

Current Prices from ISOFOL MEDICAL AB

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	ISOFOL.ST	SEK	31.10.2025 11:54	0,69 SEK	0,004 SEK +0,58 %

Share Float & Liquidity

Free Float 88,82 %

Shares Float 249,67 M

Shares Outstanding 281,11 M

Company Profile for ISOFOL MEDICAL AB Share

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.

Get up to date insights from finAgent about ISOFOL MEDICAL AB

Company Data

Name ISOFOL MEDICAL AB

Company Isofol Medical AB (publ)

Website https://isofolmedical.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2DPV6

ISIN SE0009581051

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Petter Segelman Lindqvist

Market Capitalization 242 Mio

Country Sweden

Currency SEK

Employees 0,0 T

Address Biotech Center, 413 46 Gothenburg

IPO Date 2017-04-04

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	ISOFOL.ST
Frankfurt	5IU.F

More Shares

Investors who hold ISOFOL MEDICAL AB also have the following shares in their portfolio:

GRANITE MASTER ISSUER PLC CLASS B1 FLTG RTE NTS 20/12/54 Bond

TAKEDA PHAR. 24/54 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog